Anal Fistula – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Anal Fistula Market Outlook

Thelansis’s “Anal Fistula Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Anal Fistula treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Anal Fistula Overview

An anal fistula typically develops when the anal glands located in the intersphincteric plane become blocked and infected, forming a cryptoglandular abscess. In some cases, even after drainage, up to 40% of perirectal abscesses can progress to fistulas, with spontaneously drained abscesses having a higher rate of fistula formation, reaching up to 66%. An acute or chronic anal fistula can be distressing for patients and significantly impact their quality of life. These fistulas are commonly categorized based on their anatomical positions. Classification of Anorectal Fistulas includes:

• Transphincteric fistula
• High intersphincteric fistula
• Suprasphincteric fistula
• Extrasphincteric fistula

Multiple factors contribute to the development of fistulas. The mnemonic "FRIEND" serves as a memory aid: "F" for foreign body, "R" for radiation, "I" for infection or Inflammatory Bowel Disease, "E" for epithelialization, "N" for neoplasm, and "D" for distal obstruction (as seen in the cryptoglandular theory). An anal fistula, an epithelialized connection between the anal canal and the external peri-anal area, is characterized by inflammatory and granulation tissue. The presence of distal obstruction impedes the natural healing of the fistula. The continual turnover of cells leads to constant debris within the fistula tract, causing obstruction and hindering the healing process. Utilizing a seton, a piece of material placed in the fistula exemplifies this concept as it enables continuous drainage and often results in the fistula migrating and eventually healing. Treatment for a fistula depends on its underlying cause. However, in general, an examination under anesthesia is typically performed to locate the fistulous tract using a lacrimal probe and substances like methylene blue or hydrogen peroxide. Anal fistulas typically require surgical intervention, as they rarely resolve independently without treatment. The primary treatment options encompass the following:

1. Fistulotomy: This procedure involves cutting open the entire length of the fistula, encouraging it to heal into a flat scar.
2. Seton procedures: A surgical thread, a seton, is placed within the fistula and left in position for several weeks to facilitate healing before subsequent treatment procedures are conducted. 

Geography Covered:

North America- the United States and Canada

Europe- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

Other countries- Japan & China

Study Period: 2022-2032

Current Clinical Practice and Treatment Algorithm

This section of the study covers country-specific current clinical practice, the standard of care, and significant limitations around addressing the unmet needs. Retrospective analysis and bench-marking of clinical study outcomes are presented in terms of Pre-treatment & post-treatment clinical and demographic patient characteristics. Essentially, this section will cover the evolution of the current competitive landscape and its impact on the future treatment paradigm.

KOL Insights:

KOLs across 8 MM markets from the center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs

Market Forecast: Patient Based Forecast Model (MS. Excel Based Automated Dashboard)

- Data Inputs with sourcing

- Market Event and Product Event

- Country-specific Forecast Model

- Market uptake and patient share uptake

- Attribute Analysis

- Analog Analysis

- Disease burden and pricing scenario

- Summary and Insights

NPV/ IRR Calculator-

Optimization of cash flow/ revenue flow concerning all fixed and variable investments throughout the product development process. The rate of return on an investment is a critical indicator to ensure the profitability and break-even of the project.

Competitive Landscape:

The competitive landscape includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review such as Orphan drug designation, Fast track, Priority Review, Breakthrough Therapy Designation, Rare Pediatric Disease Designation, and Accelerated Approval are tracked and supplemented with analyst commentary.

Clinical Trial Assessment-

Detailed clinical trial data analysis and critical product positioning include trial design, primary outcomes, secondary outcomes, dosing and schedules, inclusion and exclusion criteria, recruitment status and essentially covers the reported adverse events. Majorly the trial analysis helps determine the potential of the critical assets and their probable filing and launch date.

Unmet Medical Needs Overview-

This report presents the most important clinical unmet needs in the treatment, according to Thelansis research and analysis. Other essential unmet needs identified through our study include decreased cost burden on patients, improved administration convenience, and improved patient compliance.

Visit our social media pages: